Back to Supplement Finder

BioGutPro x 60 Vegetable Capsules

Sold by FMI Health

INR 33,328.00

View at FMI Health
Store
fmihealth.com
Brand
Biolongevity Labs
Product type
Peptides
Collected
2026-11-20

From the retailer

Retailer description retrieved 2026-11-20. Claims are the retailer’s, not independently verified.

Description-- BioGutPro - Advanced Gut Barrier and Regenerative Complex

Exploring Intestinal Integrity, Inflammation Modulation, and Tissue Repair

BioGutPro is a next-generation research formulation designed to assist investigators studying gut barrier function, regenerative processes, and localized inflammation. It combines seven complementary bioactive compounds - BPC-157, KPV, N-Acetyl Larazotide, GHK-Cu, CoreBiome® Tributyrin, Sodium Bicarbonate, and Zinc L-Carnosine - to create a synergistic model for exploring mucosal protection and intestinal healing.

 

Key Components of BioGutPro

  • BPC-157 (1000 mcg per serving*) – Studied for its potential to support tissue repair, angiogenesis, and gut lining protection.
  • KPV (500 mcg per serving*) – A tripeptide noted for modulating inflammatory responses and supporting immune balance in gut tissue.
  • N-Acetyl Larazotide (500 mcg per serving*) – Investigated for its role in reinforcing tight junctions and reducing intestinal permeability.
  • GHK-Cu (2 mg per serving*) – A copper-binding peptide that stimulates collagen synthesis and supports tissue regeneration.
  • CoreBiome® Tributyrin (400 mg per serving*) – A direct source of butyrate, nourishing colonocytes and promoting mucosal integrity.
  • Sodium Bicarbonate (150 mg per serving*) – Functions as a metabolic buffer, supporting optimal pH balance for nutrient absorption.
  • Zinc L-Carnosine (100 mg per serving*) – Provides antioxidant and gut-supportive properties, aiding mucosal repair.

*Serving size = 2 capsules

 

Research Focus Areas

  • Gut barrier integrity and tight junction regulation
  • Inflammation modulation and cytokine balance
  • Tissue regeneration and collagen synthesis
  • Nutrient absorption and mucosal nourishment
  • Oxidative stress reduction and antioxidant support

 

Synergistic Potential

Together, BioGutPro’s seven bioactive compounds create a comprehensive research model:

  • BPC-157 accelerates cellular repair and regeneration.
  • KPV modulates inflammatory signaling.
  • N-Acetyl Larazotide strengthens gut barrier function.
  • GHK-Cu supports collagen synthesis and tissue remodeling.
  • CoreBiome® Tributyrin nourishes colonocytes and balances the microbiome.
  • Sodium Bicarbonate maintains optimal gut pH.
  • Zinc L-Carnosine reinforces mucosal defense and repair.

This synergy provides a unique opportunity to study gut healing, inflammation modulation, and regenerative processes in preclinical models.

Research

BPC-157 and Gastrointestinal Healing - BPC-157 is a synthetic peptide investigated for its regenerative and anti-inflammatory properties. Research suggests that it supports gastrointestinal repair by promoting angiogenesis and stimulating fibroblast activity. In preclinical models, BPC-157

KPV (Lys-Pro-Val) and Inflammation Modulation - KPV

N-Acetyl Larazotide and Tight Junction Regulation - N-Acetyl Larazotide

GHK-CU and Tissue Regeneration - GHK-CU

CoreBiome® Tributyrin and Colonocyte Energy Supply - CoreBiome® Tributyrin

Sodium Bicarbonate and pH Optimization - Sodium bicarbonate

Zinc L-Carnosine and Mucosal Protection - Zinc L-carnosine

Synergistic Effects in BioGutPro

BioGutPro

  • BPC-157
  • KPV
  • N-Acetyl Larazotide
  • GHK-CU
  • CoreBiome® Tributyrin
  • Sodium Bicarbonate
  • Zinc L-Carnosine

 

Referenced Citations

  1. Sikiric P, Seiwerth S, Rucman R, et al. (2018). Stable gastric pentadecapeptide BPC 157: vascular recruitment and therapeutic potential in gastrointestinal tract injuries. Current Pharmaceutical Design, 24(18), 1990–2001.

  2. Seiwerth S, Brcic L, Klicek R, et al. (2014). Stable gastric pentadecapeptide BPC 157: an update on the development of a wound-healing agent. Expert Opinion on Biological Therapy, 14(10), 1371–1381.

  3. Catania A, Gatti S, Colombo G, Lipton JM. (2004). Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacological Reviews, 56(1), 1–29.

  4. Kelly CP, Green PH, Murray JA, et al. (2013). Safety, tolerability, and effects on markers of intestinal permeability of larazotide acetate in celiac disease: a phase I randomized trial. Alimentary Pharmacology & Therapeutics, 38(6), 659–670.

  5. Levy C, Zoratti EM, et al. (2021). Larazotide acetate for regulating tight junction integrity: a potential therapy for celiac disease. Gastroenterology & Hepatology, 17(3), 125–134.

  6. Pickart L. (2008). The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: a hypothesis. Clinical Interventions in Aging, 3(2), 329–336.

  7. McNaughton LR, Siegler J, Midgley A. (2008). Ergogenic effects of sodium bicarbonate. Current Sports Medicine Reports, 7(4), 230–236.

Label--

Molecular Structure and Data

Compound Molecular Formula CAS Number Molecular Weight
BPC-157
KPV (Lys-Pro-Val)
N-Acetyl Larazotide
GHK-Cu
CoreBiome® Tributyrin
Sodium Bicarbonate
Zinc L-Carnosine

Dosage--For Research Purposes Only